Lexaria Bioscience Corp is a biotechnology company that focuses on the development of its proprietary drug delivery technology, which enhances the bioavailability of active pharmaceutical ingredients. The company's primary goal is to improve the efficacy and speed of absorption for various compounds, particularly those related to cannabis and nicotine. Through its innovative methods, Lexaria aims to revolutionize the way these substances are consumed, potentially leading to more effective therapeutic outcomes and improved user experiences in the market for both recreational and medicinal products.